CDK5 and nervous system disorder: Numerous Cdk5 inhibitors have been reported to mitigate neurological disorders in mouse models [57,58], and some small peptides have been shown to inhibit the Cdk5–p25 complex, thereby protecting against neurodegeneration [59,60].